Published in Osteoporos Int on December 04, 2012
Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int (2014) 5.17
Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative. J Womens Health (Larchmt) (2013) 2.81
Calcium intake and risk of fracture: systematic review. BMJ (2015) 2.60
Validation of a short questionnaire for estimating dietary calcium intakes. Osteoporos Int (2014) 2.06
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2015) 1.60
Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am J Clin Nutr (2014) 1.53
Calcium supplements and cardiovascular risk in the Women's Health Initiative. Osteoporos Int (2013) 1.42
Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study. Am J Clin Nutr (2014) 1.31
Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2013) 1.05
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
Serum 25-hydroxyvitamin D, vitamin D binding protein and risk of colorectal cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Int J Cancer (2014) 0.92
Calcium supplement intake and risk of cardiovascular disease in women. Osteoporos Int (2014) 0.90
Diabetes, diabetic complications, and fracture risk. Curr Osteoporos Rep (2015) 0.88
Strontium ranelate: in search for the mechanism of action. J Bone Miner Metab (2013) 0.87
VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL). Contemp Clin Trials (2015) 0.85
Calcium supplementation increases blood creatinine concentration in a randomized controlled trial. PLoS One (2014) 0.85
Erratum and additional analyses re: Calcium plus vitamin D supplementation and the risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2016) 0.85
Association of 25-hydroxyvitamin D with areal and volumetric measures of bone mineral density and parathyroid hormone: impact of vitamin D-binding protein and its assays. Osteoporos Int (2015) 0.84
Vitamin D and cardiovascular disease: an appraisal of the evidence. Clin Chem (2013) 0.84
Mechanistic Effects of Calcitriol in Cancer Biology. Nutrients (2015) 0.82
Calcium supplements and cardiovascular risk: 5 years on. Ther Adv Drug Saf (2013) 0.80
The risks and benefits of calcium supplementation. Endocrinol Metab (Seoul) (2015) 0.79
Cross-sectional analysis of calcium intake for associations with vascular calcification and mortality in individuals with type 2 diabetes from the Diabetes Heart Study. Am J Clin Nutr (2014) 0.79
Vitamin D in the cancer patient. Curr Opin Support Palliat Care (2013) 0.78
Vitamin D Repletion in Korean Postmenopausal Women with Osteoporosis. Yonsei Med J (2016) 0.78
Longitudinal changes in calcium and vitamin D intakes and relationship to bone mineral density in a prospective population-based study: the Canadian Multicentre Osteoporosis Study (CaMos). J Musculoskelet Neuronal Interact (2013) 0.78
Elevated cardiac markers in chronic kidney disease as a consequence of hyperphosphatemia-induced cardiac myocyte injury. Med Sci Monit (2014) 0.78
Vitamin D, Calcium, and Cardiovascular Disease: A"D"vantageous or "D"etrimental? An Era of Uncertainty. Curr Atheroscler Rep (2017) 0.78
Embedding clinical interventions into observational studies. Contemp Clin Trials (2015) 0.77
Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset. PLoS One (2015) 0.76
Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to Go. Cancer Prev Res (Phila) (2015) 0.76
The association of calcium supplementation and incident cardiovascular events in the Multi-ethnic Study of Atherosclerosis (MESA). Nutr Metab Cardiovasc Dis (2016) 0.76
Calcium supplements and cardiovascular risk in the Women's Health Initiative: response to Bolland et al. Osteoporos Int (2013) 0.75
1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell. J Steroid Biochem Mol Biol (2016) 0.75
Calcium plus vitamin D supplementation and height loss: findings from the Women's Health Initiative Calcium and Vitamin D clinical trial. Menopause (2016) 0.75
Content analysis of nutritional information in paediatric oral health education leaflets. BMC Pediatr (2017) 0.75
Nutrition in Cardioskeletal Health. Adv Nutr (2016) 0.75
Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane. Osteoporos Int (2013) 0.75
Calcium revisited: part II calcium supplements and their effects. Bonekey Rep (2014) 0.75
The calcium and vitamin D controversy. Ther Adv Musculoskelet Dis (2017) 0.75
Dietary calcium intake and calcium supplementation in hungarian patients with osteoporosis. Int J Endocrinol (2013) 0.75
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periods. Osteoporos Int (2015) 0.75
Dietary Supplements and Risk of Cause-Specific Death, Cardiovascular Disease, and Cancer: A Systematic Review and Meta-Analysis of Primary Prevention Trials. Adv Nutr (2017) 0.75
Protocol for a randomized controlled trial to compare bone-loading exercises with risedronate for preventing bone loss in osteopenic postmenopausal women. BMC Womens Health (2016) 0.75
Risk of Ischemic Stroke Associated With Calcium Supplements With or Without Vitamin D: A Nested Case-Control Study. J Am Heart Assoc (2017) 0.75
Self-reported calcium use in a cohort of postmenopausal women receiving osteoporosis therapy: results from POSSIBLE US™. Osteoporos Int (2015) 0.75
Calcium and vitamin-D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice. Sci Rep (2017) 0.75
Incidence of hematologic malignancy and cause-specific mortality in the Women's Health Initiative randomized controlled trial of calcium and vitamin D supplementation. Cancer (2017) 0.75
Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials (1998) 20.39
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Ann Epidemiol (1999) 10.36
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64
The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. Ann Epidemiol (2003) 7.49
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol (2005) 4.55
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst (2008) 3.60
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol (2009) 3.33
Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. Am J Epidemiol (2008) 3.05
Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. Am J Epidemiol (2008) 2.79
Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set. Am J Clin Nutr (2011) 2.44
The Women's Health Initiative calcium-vitamin D trial: overview and baseline characteristics of participants. Ann Epidemiol (2003) 2.42
Prospective study of calcium, potassium, and magnesium intake and risk of stroke in women. Stroke (1999) 2.41
Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol (1999) 2.36
Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements. Am J Clin Nutr (2011) 2.21
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci (2009) 2.01
Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Menopause (2010) 2.00
Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94
Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. Am J Epidemiol (2006) 1.54
A prospective study of calcium intake from diet and supplements and risk of ischemic heart disease among men. Am J Clin Nutr (2003) 1.52
Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol (1998) 1.52
Evaluation of a simplified vitamin supplement inventory developed for the Women's Health Initiative. Public Health Nutr (1999) 1.45
Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Cancer Epidemiol Biomarkers Prev (2009) 1.29
Dietary supplement use by American women: challenges in assessing patterns of use, motives and costs. J Nutr (2003) 1.29
The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer (2011) 1.20
Motivations for using vitamin and mineral supplements. J Am Diet Assoc (1999) 1.06
Caution in reinterpreting the Women's Health Initiative (WHI) Calcium and Vitamin D Trial breast cancer results. Am J Clin Nutr (2012) 0.87
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med (2001) 14.48
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet (1996) 13.20
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90
Primary prevention of coronary heart disease in women through diet and lifestyle. N Engl J Med (2000) 9.05
Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study. N Engl J Med (1991) 8.66
Annual deaths attributable to obesity in the United States. JAMA (1999) 8.62
Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med (1996) 8.57
Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med (1997) 8.43
Validity and reproducibility of a food frequency interview in a Multi-Cultural Epidemiology Study. Ann Epidemiol (1999) 8.33
The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health (1997) 8.00
Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med (1995) 7.62
Folate and vitamin B6 from diet and supplements in relation to risk of coronary heart disease among women. JAMA (1998) 7.09
Plasma organochlorine levels and the risk of breast cancer. N Engl J Med (1997) 7.02
Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women. JAMA (1997) 6.92
The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med (2001) 6.37
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group. JAMA (1990) 6.25
Abdominal adiposity and coronary heart disease in women. JAMA (1998) 6.21
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Triggering of sudden death from cardiac causes by vigorous exertion. N Engl J Med (2000) 5.63
Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia (2011) 5.62
Vitamin E consumption and the risk of coronary disease in women. N Engl J Med (1993) 5.39
A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease. Ann Intern Med (2000) 5.17
Birthweight as a risk factor for breast cancer. Lancet (1996) 5.05
Intake of trans fatty acids and risk of coronary heart disease among women. Lancet (1993) 5.00
Postmenopausal hormone therapy and mortality. N Engl J Med (1997) 4.96
Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol (1997) 4.84
Dual effects of weight and weight gain on breast cancer risk. JAMA (1997) 4.81
Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up. JAMA (1992) 4.80
Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA (1995) 4.78
Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74
Weight as a risk factor for clinical diabetes in women. Am J Epidemiol (1990) 4.64
A prospective study of passive smoking and coronary heart disease. Circulation (1997) 4.51
A prospective study of pregravid determinants of gestational diabetes mellitus. JAMA (1997) 4.50
Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. BMJ (1997) 4.49
Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Intern Med (1999) 4.49
Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA (1999) 4.43
A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women. Am J Clin Nutr (2000) 4.38
Smoking cessation and decreased risk of stroke in women. JAMA (1993) 4.36
Pharmacotherapy for obesity -- do the benefits outweigh the risks? N Engl J Med (1996) 4.32
Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst (1999) 4.27
Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr (2001) 4.26
Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22
Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med (1990) 4.10
Older women with diabetes have an increased risk of fracture: a prospective study. J Clin Endocrinol Metab (2001) 4.03
Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. Am J Clin Nutr (2000) 3.99
Physical activity and risk of stroke in women. JAMA (2000) 3.95
Dietary saturated fats and their food sources in relation to the risk of coronary heart disease in women. Am J Clin Nutr (1999) 3.91
Whole-grain consumption and risk of coronary heart disease: results from the Nurses' Health Study. Am J Clin Nutr (1999) 3.89
Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst (1995) 3.88
The incidence of herpes zoster. Arch Intern Med (1995) 3.87
Continuing screening mammography in women aged 70 to 79 years: impact on life expectancy and cost-effectiveness. JAMA (1999) 3.82
Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses' Health Study. Am J Epidemiol (1997) 3.75
A prospective study of cigarette smoking and risk of cataract in men. JAMA (1992) 3.72
Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev (1995) 3.70
Self-reported breast implants and connective-tissue diseases in female health professionals. A retrospective cohort study. JAMA (1996) 3.69
The validity of recalled weight among younger women. Int J Obes Relat Metab Disord (1995) 3.68
Physical activity and coronary heart disease in women: is "no pain, no gain" passé? JAMA (2001) 3.65
Dietary patterns and the risk of coronary heart disease in women. Arch Intern Med (2001) 3.59
Body weight, weight change, and risk for hypertension in women. Ann Intern Med (1998) 3.56
Primary prevention of stroke. N Engl J Med (1995) 3.43
The primary prevention of coronary heart disease in women. N Engl J Med (1995) 3.40
Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med (1996) 3.35
Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India--the Chennai Urban Rural Epidemiology Study (CURES-17). Diabetologia (2006) 3.35
Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA (1999) 3.34
Patterns of cognitive decline in presymptomatic Alzheimer disease: a prospective community study. Arch Gen Psychiatry (2001) 3.32
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. Am J Med (1993) 3.23
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst (1999) 3.22
Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA (1999) 3.21
Prospective study of shift work and risk of coronary heart disease in women. Circulation (1995) 3.18
Body weight and longevity. A reassessment. JAMA (1987) 3.13
A prospective study of risk factors for pulmonary embolism in women. JAMA (1997) 3.12
Fish consumption and risk of sudden cardiac death. JAMA (1998) 3.06
A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis (1994) 3.05
A prospective study of body mass index, weight change, and risk of stroke in women. JAMA (1997) 3.04
The CARDIA dietary history: development, implementation, and evaluation. J Am Diet Assoc (1991) 3.04
Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr (1999) 3.03
Physical activity and risk for cardiovascular events in diabetic women. Ann Intern Med (2001) 3.01
Comparison of two methods of assessing physical activity in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Epidemiol (1991) 2.96
Birth weight and adult hypertension and obesity in women. Circulation (1996) 2.92
Contribution of vertebral deformities to chronic back pain and disability. The Study of Osteoporotic Fractures Research Group. J Bone Miner Res (1992) 2.82
Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. Arch Intern Med (2000) 2.81
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80
Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology (2000) 2.79
Very low fat diets. Circulation (1998) 2.77
Childhood socioeconomic status and risk of cardiovascular disease in middle aged US women: a prospective study. J Epidemiol Community Health (1995) 2.76
Dietary protein and risk of ischemic heart disease in women. Am J Clin Nutr (1999) 2.73
Trends in the incidence of coronary heart disease and changes in diet and lifestyle in women. N Engl J Med (2000) 2.68
Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst (1998) 2.67
The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med (2001) 2.67
Factors associated with appendicular bone mass in older women. The Study of Osteoporotic Fractures Research Group. Ann Intern Med (1993) 2.65
Body weight and mortality. A 27-year follow-up of middle-aged men. JAMA (1993) 2.65
Reproducibility and validity of an epidemiologic questionnaire to assess past year physical activity in adolescents. Am J Epidemiol (1995) 2.65
Intake of fish and omega-3 fatty acids and risk of stroke in women. JAMA (2001) 2.62
A randomized walking trial in postmenopausal women: effects on physical activity and health 10 years later. Arch Intern Med (1998) 2.62
A prospective study of weight change and health-related quality of life in women. JAMA (1999) 2.60
The use of phenome-wide association studies (PheWAS) for exploration of novel genotype-phenotype relationships and pleiotropy discovery. Genet Epidemiol (2011) 2.54